{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-061927","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2022-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.126016+00:00","generated_at":"2026-06-25T11:21:18.112868+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Pacific Biosciences CCO Peter Fromen resigns effective May 20, 2022","bullets":["Peter Fromen resigns as Chief Commercial Officer to pursue new opportunities, effective May 20, 2022.","Departure not due to any disagreement with company operations, policies, or practices.","CEO Christian Henry assumes marketing responsibilities; VP Chris Seipert takes over sales, service, and support.","Company conducting a search for a permanent Chief Commercial Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-061927","json":"https://secwatch.observer/filing/0001104659-22-061927.json","markdown":"https://secwatch.observer/filing/0001104659-22-061927.md","text":"https://secwatch.observer/filing/0001104659-22-061927.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000110465922061927/0001104659-22-061927-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000110465922061927/tm2215853d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T11:21:18.112868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a9a952b67f","claim":"Peter Fromen resigned as Chief Commercial Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..","evidence_excerpt":"On May 14, 2022, Peter Fromen, the Chief Commercial Officer of Pacific Biosciences of California, Inc. (the “Company”), notified the Company of his intention to resign, effective as of May 20, 2022, to pursue new opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000110465922061927/0001104659-22-061927-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}